213 related articles for article (PubMed ID: 8370368)
1. Potassium channel activators in vasospastic angina.
Lablanche JM; Bauters C; McFadden EP; Quandalle P; Bertrand ME
Eur Heart J; 1993 Jul; 14 Suppl B():22-4. PubMed ID: 8370368
[TBL] [Abstract][Full Text] [Related]
2. Management of vasospastic angina--role of nicorandil.
Kaski JC
Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():221-7. PubMed ID: 7647026
[TBL] [Abstract][Full Text] [Related]
3. Prevention of coronary spasm by nicorandil: comparison with nifedipine.
Lablanche JM; Bauters C; Leroy F; Bertrand ME
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S82-5. PubMed ID: 1282182
[TBL] [Abstract][Full Text] [Related]
4. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
Why HJ; Richardson PJ
Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
[TBL] [Abstract][Full Text] [Related]
5. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
Frampton J; Buckley MM; Fitton A
Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
[TBL] [Abstract][Full Text] [Related]
6. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
Goldschmidt M; Landzberg BR; Frishman WH
J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
Roland E
Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373
[TBL] [Abstract][Full Text] [Related]
8. Effect of nicorandil on coronary spasm.
Aizawa T; Ogasawara K; Nakamura F; Hirosaka A; Sakuma T; Nagashima K; Kato K
Am J Cardiol; 1989 Jun; 63(21):75J-79J. PubMed ID: 2525331
[TBL] [Abstract][Full Text] [Related]
9. Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management.
Kusama Y; Kodani E; Nakagomi A; Otsuka T; Atarashi H; Kishida H; Mizuno K
J Nippon Med Sch; 2011; 78(1):4-12. PubMed ID: 21389642
[TBL] [Abstract][Full Text] [Related]
10. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina.
Sun H; Mohri M; Shimokawa H; Usui M; Urakami L; Takeshita A
J Am Coll Cardiol; 2002 Mar; 39(5):847-51. PubMed ID: 11869851
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of Vasospastic Angina.
Harris JR; Hale GM; Dasari TW; Schwier NC
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):439-51. PubMed ID: 27081186
[TBL] [Abstract][Full Text] [Related]
12. Effect of a new coronary vasodilator, nicorandil, on variant angina pectoris.
Kishida H; Murao S
Clin Pharmacol Ther; 1987 Aug; 42(2):166-74. PubMed ID: 2955996
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
Guermonprez JL; Blin P; Peterlongo F
Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
[TBL] [Abstract][Full Text] [Related]
14. Coronary microvascular spasm in patients with vasospastic angina.
Hellstrom HR
J Am Coll Cardiol; 2002 Aug; 40(3):573-4. PubMed ID: 12142130
[No Abstract] [Full Text] [Related]
15. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
Kato K
Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of potassium channel activators in coronary heart disease.
Haeusler G; Lues I
Eur Heart J; 1994 Aug; 15 Suppl C():82-8. PubMed ID: 7995277
[TBL] [Abstract][Full Text] [Related]
17. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
Suryapranata H
Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
[TBL] [Abstract][Full Text] [Related]
18. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
Aizawa T; Ogasawara K; Kato K
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
[TBL] [Abstract][Full Text] [Related]
19. Multivessel coronary spasm during coronary angiography: coronary vasospastic disease.
Gowda RM; Khan IA; Patlola RR; Vasavada BC; Sacchi TJ
Int J Cardiol; 2003 Jun; 89(2-3):301-2. PubMed ID: 12767558
[No Abstract] [Full Text] [Related]
20. Nicorandil for angina.
Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
